124 related articles for article (PubMed ID: 38250530)
1. Podocalyxin in the onset of nephropathy among Indian type 2 diabetes mellitus patients.
Viswanatha Setty B; Gutlur Nagarajaiah Setty R; Rangaswamaiah H; Veluri G
Bioinformation; 2023; 19(12):1124-1128. PubMed ID: 38250530
[TBL] [Abstract][Full Text] [Related]
2. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
[No Abstract] [Full Text] [Related]
3. Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria.
Kostovska I; Tosheska-Trajkovska K; Topuzovska S; Cekovska S; Spasovski G; Kostovski O; Labudovic D
J Med Biochem; 2020 Jan; 39(1):83-90. PubMed ID: 32549781
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy.
Ganesh V; M M; Palem SP
Cureus; 2022 Jul; 14(7):e27308. PubMed ID: 36039271
[TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.
Asghar S; Asghar S; Mahmood T; Bukhari SMH; Mumtaz MH; Rasheed A
Cureus; 2023 Aug; 15(8):e43190. PubMed ID: 37692611
[TBL] [Abstract][Full Text] [Related]
6. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
7. Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus.
Son MK; Yoo HY; Kwak BO; Park HW; Kim KS; Chung S; Chae HW; Kim HS; Kim DH
Ann Pediatr Endocrinol Metab; 2015 Mar; 20(1):13-20. PubMed ID: 25883922
[TBL] [Abstract][Full Text] [Related]
8. Does serum kidney injury molecule-1 predict early diabetic nephropathy: A comparative study with microalbuminuria.
Balu D; Krishnan V; Krishnamoorthy V; Singh RBS; Narayanasamy S; Ramanathan G
Ann Afr Med; 2022; 21(2):136-139. PubMed ID: 35848645
[TBL] [Abstract][Full Text] [Related]
9. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
[TBL] [Abstract][Full Text] [Related]
10. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study.
Sánchez-Hidalgo JJ; Suárez-Cuenca JA; Lozano-Nuevo JJ; García-López VH; Leal-Gutiérrez MG; León-Angel SA; Ramírez-Villa ML; Rodea-Rubio ME; González-Hernández JE; Canela-Mayoral JA; Murillo-Heredia E; Vera-Gómez E; Hernández-Patricio A; Zamora-Alemán CR; Domínguez-Pérez GA; Gutiérrez-Buendia JA; Mondragón-Terán P
Diabetol Metab Syndr; 2021 Nov; 13(1):128. PubMed ID: 34743740
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes.
Bezen D; Vurgun E; Dursun H
Pediatr Nephrol; 2023 Nov; 38(11):3693-3698. PubMed ID: 37204490
[TBL] [Abstract][Full Text] [Related]
12. Urinary Nephrin is a Sensitive Marker to Predict Early Onset of Nephropathy in Type 2 Diabetes Mellitus.
Veluri G; Mannangatti M
J Lab Physicians; 2022 Dec; 14(4):497-504. PubMed ID: 36531542
[No Abstract] [Full Text] [Related]
13. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
14. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
15. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Heidari Z; Gharebaghi A
J Clin Diagn Res; 2017 May; 11(5):OC04-OC07. PubMed ID: 28658824
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Glomerular and Tubular Function in the Evaluation of Diabetic Nephropathy: A Cross-sectional Study.
Agarwal SK; Saikia UK; Sarma D; Devi R
Indian J Endocrinol Metab; 2018; 22(4):451-456. PubMed ID: 30148087
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Microalbuminuria among Rural North Indian Population with Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin and Smoking.
Aggarwal J; Kumar M
J Clin Diagn Res; 2014 Jul; 8(7):CC11-3. PubMed ID: 25177561
[TBL] [Abstract][Full Text] [Related]
19. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
20. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
